BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4775646)

  • 1. [Supra-additive natriuretic effect of theophyllamine in patients with chronic congestive heart failure during long-term therapy with bumethanide].
    Sigurd B
    Ugeskr Laeger; 1973 Oct; 135(41):2218-22. PubMed ID: 4775646
    [No Abstract]   [Full Text] [Related]  

  • 2. Bumetanide: a new potent diuretic. The effects of a single intravenous dose in patients with congestive heart failure.
    Sigurd B; Hesse B; Valentin N
    Dan Med Bull; 1974 Apr; 21(2):63-7. PubMed ID: 4830521
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carbohydrate metabolism during short-term bumethanide therapy].
    Madsen S; Gronbaek P
    Ugeskr Laeger; 1973 Oct; 135(41):2215-7. PubMed ID: 4775645
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bumetanide, a new diuretic. A clinical assessment of the diuretic effect in patients with chronic congestive heart failure].
    Sigurd B; Leth A; Steiness E
    Ugeskr Laeger; 1973 Feb; 135(9):461-5. PubMed ID: 4703493
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trial of a new diuretic, bumetanide, in seriously ill patients.
    Runeberg L; Pasternack A; Borgmästars H; von Bonsdorff M
    Ann Clin Res; 1974 Oct; 6(5):272-8. PubMed ID: 4614693
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation in man of bumetanide, a new diuretic agent.
    Henning R; Lundvall O
    Eur J Clin Pharmacol; 1973 Dec; 6(4):224-7. PubMed ID: 4777256
    [No Abstract]   [Full Text] [Related]  

  • 7. Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.
    Olesen KH; Sigurd B; Steiness E; Leth A
    Acta Med Scand; 1973; 193(1-2):119-31. PubMed ID: 4574445
    [No Abstract]   [Full Text] [Related]  

  • 8. The sites of action of bumetanide in man.
    Bourke E; Asbury MJ; O'Sullivan S; Gatenby PB
    Eur J Pharmacol; 1973 Sep; 23(3):283-9. PubMed ID: 4583564
    [No Abstract]   [Full Text] [Related]  

  • 9. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
    Sigurd B; Olesen KH; Wennevold A
    Am Heart J; 1975 Feb; 89(2):163-70. PubMed ID: 1090132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of glomerular filtration rate and renal plasma flow following intravenous bumetanide in organic heart disease.
    Bollerup AC; Hesse B; Sigurd B
    Acta Pharmacol Toxicol (Copenh); 1974 May; 34(5):305-11. PubMed ID: 4406929
    [No Abstract]   [Full Text] [Related]  

  • 11. The supra-additive natriuretic effect addition of theophylline ethylenediamine and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
    Sigurd B; Olesen KH
    Am Heart J; 1977 Aug; 94(2):168-74. PubMed ID: 406769
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bumetanide. A comparison between the diuretic effect of bumetanide and furosemide in patients with chronic congestive heart failure].
    Sigurd B; Leth A; Steiness E
    Ugeskr Laeger; 1973 Feb; 135(9):466-71. PubMed ID: 4703494
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative natriuretic and diuretic efficacy of theophylline ethylenediamine and of bendroflumethiazide during long-term treatment with the potent diuretic bumetanide. Permutation trial tests in patients with congestive heart failure.
    Sigurd B; Olesen KH
    Acta Med Scand; 1978; 203(1-2):113-9. PubMed ID: 343509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of bumetanide, a new saluretic agent.
    Karlander SG; Henning R; Lundvall O
    Eur J Clin Pharmacol; 1973 Dec; 6(4):220-3. PubMed ID: 4777255
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of potassium chloride and triamterene on kaliuresis, natriuresis and diuresis in congestive heart failure].
    Kabakov AI; Zharov EI
    Klin Med (Mosk); 1995; 73(5):33-5. PubMed ID: 8815272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure.
    Olesen KH; Sigurd B
    Acta Med Scand; 1971 Sep; 190(3):233-40. PubMed ID: 4941227
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of potent diuretics in renal failure].
    Kawaguchi Y; Sakai S; Yamamoto M; Tanaka S; Oda Y
    Nihon Rinsho; 1974 Aug; 32(8):2636-43. PubMed ID: 4612209
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of bumetanide in the treatment of ascites due to liver disease.
    Moult PJ; Lunzer MR; Trash DB; Sherlock S
    Gut; 1974 Dec; 15(12):988-92. PubMed ID: 4448415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide.
    Davies DL; Lant AF; Millard NR; Smith AJ; Ward JW; Wilson GM
    Clin Pharmacol Ther; 1974 Feb; 15(2):141-55. PubMed ID: 4590799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.